VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH CML 2022 | ESH CML highlights: the role of metabolism in CML & novel methods to predict response to treatment

Daniela Krause, MD, Georg-Speyer-Haus, Goethe University, Frankfurt, Germany, shares some of her highlights from the ESH CML meeting, discussing the role of metabolism in chronic myeloid leukemia (CML) and the possibility to predict treatment outcomes using markers identified with single-cell technologies and by measuring residual disease in granulocytes, and highlighting a novel promising combination strategy. This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Research Support from Merck KGaA

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter